Short description
Adnavance Technologies develops direct detection molecular diagnostic tests for medical applications.
Description
Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2002
Closed on
May 26, 2010
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccess, Uh Ohhhh, Noaccess, Absolutely Noaccess, Absolutely Noaccess
Sign in for full access